HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of tumor cell invasion and matrix degradation by aminopeptidase inhibitors.

Abstract
We investigated the effects of several types of aminopeptidase inhibitors on tumor cell-associated aminopeptidase activity and invasion. The aminopeptidase expressed by the human metastatic HT1080 fibrosarcoma cells was effectively suppressed by actinonin A, bestatin, leuhistin and matlystatin A, which are capable of inhibiting the purified aminopeptidase N, but not by arphamenine B specific for aminopeptidase B. The aminopeptidase N inhibitors inhibited HT1080 cells from degrading the subendothelial matrix and from invading into Matrigel in parallel with their aminopeptidase inhibitory activities. Matlystatin A, with multiple inhibitory activity against both aminopeptidase N and matrix metalloproteinases (MMP), was the most effective inhibitor of invasion. However, leuhistin and bestatin, without MMP inhibitory activity, also exhibited significant inhibition of invasion. The results suggest that aminopeptidase N plays a crucial role in the degradation and invasion of extracellular matrices by fibrosarcoma cells and that aminopeptidase inhibitors may be useful for preventing the spread of malignant tumors.
AuthorsH Fujii, M Nakajima, T Aoyagi, T Tsuruo
JournalBiological & pharmaceutical bulletin (Biol Pharm Bull) Vol. 19 Issue 1 Pg. 6-10 (Jan 1996) ISSN: 0918-6158 [Print] Japan
PMID8820902 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Aminopeptidases
  • Gelatinases
Topics
  • Aminopeptidases (antagonists & inhibitors)
  • Antineoplastic Agents (pharmacology)
  • Endothelium, Vascular (cytology, drug effects, enzymology)
  • Enzyme Inhibitors (pharmacology)
  • Extracellular Matrix (drug effects)
  • Fibrosarcoma (drug therapy, pathology)
  • Gelatinases (antagonists & inhibitors)
  • Humans
  • Neoplasm Invasiveness
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: